Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis

Amalia Penna, Diletta Laccabue, Irene Libri, Tiziana Giuberti, Simona Schivazappa, Arianna Alfieri, Cristina Mori, Diana Canetti, Pietro Lampertico, Mauro Viganò, Massimo Colombo, Elisabetta Loggi, Gabriele Missale, Carlo Ferrari

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background & Aims: The effect of IFN-α therapy on HBV-specific T-cell responses in HBeAg-negative, genotype D, chronic hepatitis B is largely undefined. Understanding to what extent IFN-α can modulate HBV-specific T-cells is important to define strategies to optimize IFN efficacy and to identify immunological parameters to predict response to therapy. Methods: HBV-specific T-cell responses were analyzed longitudinally ex vivo and after expansion in vitro in 15 patients with genotype D, HBeAg-negative chronic hepatitis B treated with peginterferon-α-2a. HBV proteins and synthetic peptides were used to stimulate T-cell responses. Analysis of the CD4 and CD8 T-cell functions was performed by ELISPOT, intracellular cytokine and tetramer staining. The effect of anti-PD-L1 on T-cell functions was also analyzed. Results: Ex vivo IFN-γ production by total HBV-specific T-cells was significantly greater before therapy in patients who showed HBV DNA

Original languageEnglish
Pages (from-to)1239-1246
Number of pages8
JournalJournal of Hepatology
Volume56
Issue number6
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Hepatitis B e Antigens
Chronic Hepatitis
T-Lymphocytes
Chronic Hepatitis B
Genotype
Enzyme-Linked Immunospot Assay
Therapeutics
Staining and Labeling
Cytokines
Peptides
DNA

Keywords

  • Adaptive immunity
  • Antiviral therapy
  • Cytokines
  • PD-1

ASJC Scopus subject areas

  • Hepatology

Cite this

Penna, A., Laccabue, D., Libri, I., Giuberti, T., Schivazappa, S., Alfieri, A., ... Ferrari, C. (2012). Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis. Journal of Hepatology, 56(6), 1239-1246. https://doi.org/10.1016/j.jhep.2011.12.032

Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis. / Penna, Amalia; Laccabue, Diletta; Libri, Irene; Giuberti, Tiziana; Schivazappa, Simona; Alfieri, Arianna; Mori, Cristina; Canetti, Diana; Lampertico, Pietro; Viganò, Mauro; Colombo, Massimo; Loggi, Elisabetta; Missale, Gabriele; Ferrari, Carlo.

In: Journal of Hepatology, Vol. 56, No. 6, 06.2012, p. 1239-1246.

Research output: Contribution to journalArticle

Penna, A, Laccabue, D, Libri, I, Giuberti, T, Schivazappa, S, Alfieri, A, Mori, C, Canetti, D, Lampertico, P, Viganò, M, Colombo, M, Loggi, E, Missale, G & Ferrari, C 2012, 'Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis', Journal of Hepatology, vol. 56, no. 6, pp. 1239-1246. https://doi.org/10.1016/j.jhep.2011.12.032
Penna, Amalia ; Laccabue, Diletta ; Libri, Irene ; Giuberti, Tiziana ; Schivazappa, Simona ; Alfieri, Arianna ; Mori, Cristina ; Canetti, Diana ; Lampertico, Pietro ; Viganò, Mauro ; Colombo, Massimo ; Loggi, Elisabetta ; Missale, Gabriele ; Ferrari, Carlo. / Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis. In: Journal of Hepatology. 2012 ; Vol. 56, No. 6. pp. 1239-1246.
@article{dd431da1b34140c6a96e859e4753d5c8,
title = "Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis",
abstract = "Background & Aims: The effect of IFN-α therapy on HBV-specific T-cell responses in HBeAg-negative, genotype D, chronic hepatitis B is largely undefined. Understanding to what extent IFN-α can modulate HBV-specific T-cells is important to define strategies to optimize IFN efficacy and to identify immunological parameters to predict response to therapy. Methods: HBV-specific T-cell responses were analyzed longitudinally ex vivo and after expansion in vitro in 15 patients with genotype D, HBeAg-negative chronic hepatitis B treated with peginterferon-α-2a. HBV proteins and synthetic peptides were used to stimulate T-cell responses. Analysis of the CD4 and CD8 T-cell functions was performed by ELISPOT, intracellular cytokine and tetramer staining. The effect of anti-PD-L1 on T-cell functions was also analyzed. Results: Ex vivo IFN-γ production by total HBV-specific T-cells was significantly greater before therapy in patients who showed HBV DNA",
keywords = "Adaptive immunity, Antiviral therapy, Cytokines, PD-1",
author = "Amalia Penna and Diletta Laccabue and Irene Libri and Tiziana Giuberti and Simona Schivazappa and Arianna Alfieri and Cristina Mori and Diana Canetti and Pietro Lampertico and Mauro Vigan{\`o} and Massimo Colombo and Elisabetta Loggi and Gabriele Missale and Carlo Ferrari",
year = "2012",
month = "6",
doi = "10.1016/j.jhep.2011.12.032",
language = "English",
volume = "56",
pages = "1239--1246",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier B.V.",
number = "6",

}

TY - JOUR

T1 - Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis

AU - Penna, Amalia

AU - Laccabue, Diletta

AU - Libri, Irene

AU - Giuberti, Tiziana

AU - Schivazappa, Simona

AU - Alfieri, Arianna

AU - Mori, Cristina

AU - Canetti, Diana

AU - Lampertico, Pietro

AU - Viganò, Mauro

AU - Colombo, Massimo

AU - Loggi, Elisabetta

AU - Missale, Gabriele

AU - Ferrari, Carlo

PY - 2012/6

Y1 - 2012/6

N2 - Background & Aims: The effect of IFN-α therapy on HBV-specific T-cell responses in HBeAg-negative, genotype D, chronic hepatitis B is largely undefined. Understanding to what extent IFN-α can modulate HBV-specific T-cells is important to define strategies to optimize IFN efficacy and to identify immunological parameters to predict response to therapy. Methods: HBV-specific T-cell responses were analyzed longitudinally ex vivo and after expansion in vitro in 15 patients with genotype D, HBeAg-negative chronic hepatitis B treated with peginterferon-α-2a. HBV proteins and synthetic peptides were used to stimulate T-cell responses. Analysis of the CD4 and CD8 T-cell functions was performed by ELISPOT, intracellular cytokine and tetramer staining. The effect of anti-PD-L1 on T-cell functions was also analyzed. Results: Ex vivo IFN-γ production by total HBV-specific T-cells was significantly greater before therapy in patients who showed HBV DNA

AB - Background & Aims: The effect of IFN-α therapy on HBV-specific T-cell responses in HBeAg-negative, genotype D, chronic hepatitis B is largely undefined. Understanding to what extent IFN-α can modulate HBV-specific T-cells is important to define strategies to optimize IFN efficacy and to identify immunological parameters to predict response to therapy. Methods: HBV-specific T-cell responses were analyzed longitudinally ex vivo and after expansion in vitro in 15 patients with genotype D, HBeAg-negative chronic hepatitis B treated with peginterferon-α-2a. HBV proteins and synthetic peptides were used to stimulate T-cell responses. Analysis of the CD4 and CD8 T-cell functions was performed by ELISPOT, intracellular cytokine and tetramer staining. The effect of anti-PD-L1 on T-cell functions was also analyzed. Results: Ex vivo IFN-γ production by total HBV-specific T-cells was significantly greater before therapy in patients who showed HBV DNA

KW - Adaptive immunity

KW - Antiviral therapy

KW - Cytokines

KW - PD-1

UR - http://www.scopus.com/inward/record.url?scp=84861184620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861184620&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2011.12.032

DO - 10.1016/j.jhep.2011.12.032

M3 - Article

VL - 56

SP - 1239

EP - 1246

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 6

ER -